Logo
x

Search

Subscribe Now

Indications

Merck's Brenzys (etanercept- biosimilar) Receives Health Canada Approval for Multiple Indications

Merck's Brenzys (etanercept- biosimilar) Receives Health Canada Approval for Multiple Indications

  • September 16, 2020
Roche Reports the US FDA's Acceptance of sBLA for Xolair (omalizumab) Prefilled Syringe for Self-Administration Across All Indications

Roche Reports the US FDA's Acceptance of sBLA for Xolair (omalizumab) Prefilled Syringe for Self-Administration Across All Indicat...

  • August 13, 2020
Samsung Bioepis' Aybintio (biosimilar- bevacizumab) Receives CHMP's Positive Opinion to Treat Multiple Cancer Indications

Samsung Bioepis' Aybintio (biosimilar- bevacizumab) Receives CHMP's Positive Opinion to Treat Multiple Cancer Indications

  • June 29, 2020
Thermo Fisher Scientific Collaborates with Janssen to Co-Develop CDx for Multiple Cancer Indications

Thermo Fisher Scientific Collaborates with Janssen to Co-Develop CDx for Multiple Cancer Indications

  • March 12, 2020
Mount Sinai Signs a Multi-Year Collaboration with Harbour BioMed to Develop Novel Biotherapies for Multiple Cancer Indications and COVID-19

Mount Sinai Signs a Multi-Year Collaboration with Harbour BioMed to Develop Novel Biotherapies for Multiple Cancer Indications and...

  • March 6, 2020
GSK Signs an Agreement with Immatics to Develop Adoptive Cell Therapies for Multiple Cancer Indications

GSK Signs an Agreement with Immatics to Develop Adoptive Cell Therapies for Multiple Cancer Indications

  • February 21, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.